SAMJO CAPITAL LLC
Q1 2021 Form 13-F
CIK 0001509943
· Institutional investment manager
$134.8M Reported Value Total
Reported value
$134.8M
Quarter over quarter
+18.2%
Holdings
19
Top-10 concentration
84.2%
Filing Structure
Reports holdings for
- Samjo Management LLC · Q3 2023 – Q3 2023 · declared by one filing
Holdings reported by
- Samjo Management LLC · Q4 2023 – Q4 2023 · declared by one filing
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Andrew Wiener
Managing Member
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2021 13F record
Q1 2021 13F filing summary
| Period of report | March 31, 2021 |
|---|---|
| Filed | May 12, 2021 |
| Form | 13F-HR |
| Reported value | $134.8M |
| Positions | 19 |
| Change in reported value | +15.0% |
| New positions | 4 |
| Exited positions | 2 |
| Position turnover | 28.6% |
| Top-10 concentration | 84.2% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2023 13F
Filed Nov 14, 2023
|
47 | $254.2M |
|
Q2 2023 13F
Filed Aug 9, 2023
|
12 | $119.3M |
|
Q1 2023 13F
Filed May 10, 2023
|
13 | $110.2M |
|
Q4 2022 13F
Filed Feb 8, 2023
|
13 | $94.9M |
|
Q3 2022 13F
Filed Nov 7, 2022
|
14 | $81.9M |
|
Q2 2022 13F
Filed Aug 4, 2022
|
18 | $82.0M |
|
Q1 2022 13F
Filed May 16, 2022
|
18 | $116.9M |
|
Q4 2021 13F
Filed Feb 8, 2022
|
17 | $149.2M |
|
Q3 2021 13F
Filed Nov 12, 2021
|
18 | $136.2M |
|
Q2 2021 13F
Filed Aug 13, 2021
|
19 | $147.7M |
|
Q1 2021 13F
Filed May 12, 2021
|
19 | $134.8M |
|
Q4 2020 13F
Filed Feb 11, 2021
|
17 | $117.2M |
Top 20 holdings · Q1 2021
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | QUOT QUOTIENT TECHNOLOGY INC | $39.2M | 29.09% |
| 2 | PDFS PDF SOLUTIONS INC | $21.6M | 16.04% |
| 3 | INOV INOVALON HLDGS INC | $11.4M | 8.43% |
| 4 | VG VONAGE HLDGS CORP | $9.1M | 6.75% |
| 5 | ITI ITERIS INC NEW | $8.0M | 5.9% |
| 6 | ASPN ASPEN AEROGELS INC | $7.0M | 5.21% |
| 7 | GAN GAN LTD | $5.4M | 3.98% |
| 8 | SCOR COMSCORE INC | $4.5M | 3.31% |
| 9 | LAB FLUIDIGM CORP DEL | $3.7M | 2.73% |
| 10 | NEPH NEPHROS INC | $3.7M | 2.71% |
| 11 | RSSS RESEARCH SOLUTIONS INC | $3.4M | 2.51% |
| 12 | THRY THRYV HLDGS INC | $2.7M | 2.0% |
| 13 | SHSP SHARPSPRING INC | $2.6M | 1.96% |
| 14 | XGN EXAGEN INC | $2.6M | 1.95% |
| 15 | HTGM HTG MOLECULAR DIAGNOSTICS IN | $2.4M | 1.74% |
| 16 | FRG FRANCHISE GROUP INC | $2.2M | 1.61% |
| 17 | AXDX 2.5 03/15/23 ACCELERATE DIAGNOSTICS INC | $1.8M | 1.32% |
| 18 | SCTL RECRO PHARMA INC | $1.6M | 1.16% |
| 19 | TACT TRANSACT TECHNOLOGIES INC | $1.4M | 1.05% |
| 20 | DMRC DIGIMARC CORP NEW | $742.0K | 0.55% |
Values as reported on the Q1 2021 Form 13F. Every position is in the holdings table below.